<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1374179</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1374179</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Glycyrrhiza uralensis</italic> polysaccharides ameliorates cecal ligation and puncture-induced sepsis by inhibiting the cGAS-STING signaling pathway</article-title>
<alt-title alt-title-type="left-running-head">Hui et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1374179">10.3389/fphar.2024.1374179</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Hui</surname>
<given-names>Siwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2636148/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kan</surname>
<given-names>Wen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Qin</surname>
<given-names>Shuanglin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1493806/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>He</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Jia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bai</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Jincai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mou</surname>
<given-names>Wenqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2316067/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Manting</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Ziying</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2541803/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Xiaohe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2078638/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xu</surname>
<given-names>Guang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/806300/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bai</surname>
<given-names>Zhaofang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/305790/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Hepatology</institution>, <institution>The Fifth Medical Center of Chinese PLA General Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>China Military Institute of Chinese Materia</institution>, <institution>Fifth Medical Center of Chinese PLA General Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Pharmacy</institution>, <institution>Xianning Medical College</institution>, <institution>Hubei University of Science and Technology</institution>, <addr-line>Xianning</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Neurosurgery</institution>, <institution>General Hospital of Chinese People Liberty Army</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>School of Traditional Chinese Medicine</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/715217/overview">Wei Peng</ext-link>, Chengdu University of Traditional Chinese Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2683119/overview">Pei Hongyan</ext-link>, Jilin Agriculture University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2718041/overview">Mengmeng Zhang</ext-link>, Shaanxi University of Chinese Medicine, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhaofang Bai, <email>baizf2008@hotmail.com</email>; Guang Xu, <email>guang_xu@ccmu.edu.cn</email>; Xiaohe Xiao, <email>pharmacy_302@126.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1374179</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Hui, Kan, Qin, He, Zhao, Li, Bai, Wen, Mou, Hou, Wei, Lin, Xiao, Xu and Bai.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Hui, Kan, Qin, He, Zhao, Li, Bai, Wen, Mou, Hou, Wei, Lin, Xiao, Xu and Bai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Ethnopharmacological relevance:</bold> <italic>G. uralensis Fisch.</italic> (<italic>Glycyrrhiza uralensis</italic>) is an ancient and widely used traditional Chinese medicine with good efficacy in clearing heat and detoxifying action. Studies suggest that <italic>Glycyrrhiza Uralensis</italic> Polysaccharides (GUP), one of the major components of <italic>G. uralensis,</italic> has anti-inflammatory, anti-cancer and hepatoprotective effects., but its exact molecular mechanism has not been explored in depth.</p>
<p>
<bold>Aim of the study:</bold> Objectives of our research are about exploring the anti-inflammatory role of GUP and the mechanisms of its action.</p>
<p>
<bold>Materials and methods:</bold> ELISA kits, Western blotting, immunofluorescence, quantitative real-time PCR, immunoprecipitation and DMXAA-mediated STING activation mice models were performed to investigate the role of GUP on the cGAS-STING pathway. To determine the anti-inflammatory effects of GUP, cecal ligation and puncture (CLP) sepsis models were employed.</p>
<p>
<bold>Results:</bold> GUP could effectively inhibit the activation of the cGAS-STING signaling pathway accompany by a decrease the expression of type I interferon-related genes and inflammatory factors in BMDMs, THP-1, and human PBMCs. Mechanistically, GUP does not affect the oligomerization of STING, but affects the interaction of STING with TBK1 and TBK1 with IRF3. Significantly, GUP had great therapeutic effects on DMXAA-induced agonist experiments <italic>in vivo</italic> as well as CLP sepsis in mice.</p>
<p>
<bold>Conclusion:</bold> Our studies suggest that GUP is an effective inhibitor of the cGAS-STING pathway, which may be a potential medicine for the treatment of inflammatory diseases mediated by the cGAS-STING pathway.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<caption>
<p>GUP can effectively inhibit the activation of cGAS-STING pathway induced by multiple stimuli and reduce the expression of type I interferon and pro-inflammatory cytokines. Meanwhile GUP also has a good therapeutic effect on sepsis contributed to cecum ligation and puncture.</p>
</caption>
<graphic xlink:href="FPHAR_fphar-2024-1374179_wc_abs.tif" position="anchor"/>
</fig>
</p>
</abstract>
<kwd-group>
<kwd>
<italic>Glycyrrhiza uralensis</italic> fisch.</kwd>
<kwd>
<italic>Glycyrrhiza uralensis</italic> polysaccharides</kwd>
<kwd>cGAS-STING pathway</kwd>
<kwd>sepsis</kwd>
<kwd>cecal ligation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Sepsis is a systemic inflammatory response caused by bacterial or fungal infection; life-threatening multiple organ dysfunction developed as the disease progresses (<xref ref-type="bibr" rid="B47">Singer et al., 2016</xref>). Septic shock and sepsis are serious health problems that affect millions of people worldwide every year. They rank among the top ten leading causes of death and morbidity worldwide (<xref ref-type="bibr" rid="B9">Cheng et al., 2015</xref>). Despite excellent success achieved in early detection and emergency response management, sepsis remains an important factor in the death of infected patients (<xref ref-type="bibr" rid="B14">Fleischmann-Struzek et al., 2020</xref>). The CLP mice model has become the most widely used model for experimental sepsis and is now considered the gold standard for sepsis research (<xref ref-type="bibr" rid="B11">Dejager et al., 2011</xref>; <xref ref-type="bibr" rid="B65">Zoulikha et al., 2022</xref>). At the onset of sepsis, a systemic inflammatory response occurs, followed by septic shock, multi-organ dysfunction, and ultimately death. In the CLP mice model, multiple foci of microbial infection occur in the abdominal cavity, subsequently triggering a systemic inflammatory response. Studies have shown that ligation of the mouse cecum results in elevated levels of apoptosis and increased secretion of pro-inflammatory cytokines and interferon in the mouse intestinal epithelium (<xref ref-type="bibr" rid="B4">Buras et al., 2005</xref>). The search for precursor compounds that may be effective against sepsis by studying models of cecum ligation is an important approach to the clinical treatment of sepsis.</p>
<p>Recent studies indicate that the cGAS-STING pathway is an important immune response pathway in the organism and plays an important role in the regulation of pathological states such as infection and inflammation. The process of activation of the cGAS-STING pathway is associated with abnormal release of DNA from organisms infected with viruses, bacteria, parasites or intracellular DNA. The cytoplasmic pattern recognition receptor cGAS can be activated by exogenous DNA, DNA released by damaged cells and mitochondrial leakage of DNA as well as by intracellularly production of micronuclei, catalyzing the creation of second messenger cGAMP and stimulating STING signaling (<xref ref-type="bibr" rid="B56">Wu et al., 2013</xref>; <xref ref-type="bibr" rid="B10">Decout et al., 2021</xref>). After leaving the endoplasmic reticulum, STING moves to the Golgi apparatus and eventually to the perinuclear endosome, where it interacts with TNBK-binding kinase-1 (TBK1) (<xref ref-type="bibr" rid="B27">Kwon and Bakhoum, 2020</xref>). TBK1 then phosphorylates STING, IRF3 and TRAF6, as well as its self, leading to the release of type I interferon and other inflammatory cytokines (<xref ref-type="bibr" rid="B56">Wu et al., 2013</xref>; <xref ref-type="bibr" rid="B15">Fr&#xe9;mond and Crow, 2021</xref>). A increasing amount of researches have shown that the immoderate activation of cGAS-STING pathway could trigger a range of inflammatory responses and autoimmune diseases, including alcoholic liver disease (<xref ref-type="bibr" rid="B7">Chen R. et al., 2021</xref>), ischemic brain injury (<xref ref-type="bibr" rid="B28">Li et al., 2023</xref>) and rheumatoid arthritis (<xref ref-type="bibr" rid="B50">Wang J. et al., 2019</xref>). Studies indicate that aberrant activation of the cGAS-STING pathway plays an important role in the onset and progression of sepsis, and that during the occurrence of an infection, bacterial viruses or other pathogens activate the cGAS-STING pathway, which triggers the production of intracellular signals including interferon and other inflammatory signals. (<xref ref-type="bibr" rid="B29">Li J. et al., 2022</xref>). Targeted modulation of the cGAS-STING pathway may be an important strategy for the treatment of sepsis.</p>
<p>
<italic>Glycyrrhiza uralensis</italic> Fisch. (<italic>Glycyrrhiza uralensis</italic>) is an ancient and widely-used traditional Chinese medicine, with the effects of tonifying the spleen, benefiting the qi, clearing heat and detoxifying the toxin, which has been recorded in many national pharmacopoeias (<xref ref-type="bibr" rid="B23">Jiang et al., 2022</xref>; <xref ref-type="bibr" rid="B34">Liu et al., 2023</xref>). In addition, <italic>G. uralensis</italic> has such functions as anti-cancer (<xref ref-type="bibr" rid="B37">Luo et al., 2021</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B30">Li Q. et al., 2022</xref>; <xref ref-type="bibr" rid="B48">Sun et al., 2022</xref>), liver protection (<xref ref-type="bibr" rid="B45">Rizzato et al., 2017</xref>) and other pharmacological activities (<xref ref-type="bibr" rid="B49">Wahab et al., 2021</xref>). The manifestation of these pharmacological effects is mainly dependent on the chemical composition of <italic>G. uralensis</italic>. Studies have confirmed that Glycyrrhizic acid suppresses inflammatory reaction by inhibiting NF-&#x3ba;B and MAPK pathways, which has a protective effect against sepsis-induced acute lung injury (<xref ref-type="bibr" rid="B18">Gu et al., 2022</xref>; <xref ref-type="bibr" rid="bib66">Yang et al., 9900</xref>). Glycyrrhizin has been shown to inhibit activation of the HMGB1/TLR9 pathway to alleviate sepsis-induced acute respiratory distress syndrome (<xref ref-type="bibr" rid="B63">Zhao et al., 2016</xref>). In addition, licorice flavonoids, licorice extracts, Licochalcone B, and Glabridin have all been shown to have significant inhibitory effects on the cGAS-STING pathway and its mediated inflammatory disorders (<xref ref-type="bibr" rid="B54">Wen et al., 2023a</xref>; <xref ref-type="bibr" rid="B55">Wen et al., 2023b</xref>; <xref ref-type="bibr" rid="B36">Luo et al., 2023</xref>; <xref ref-type="bibr" rid="B35">Luo et al., 2024</xref>). Therefore, we speculate that GUP, a major component of licorice, may also have an effect on the cGAS-STING pathway. Recent studies also depicted that polysaccharides and other <italic>G. uralensis</italic> extracts are the main active components with potent biological and pharmacological activities (<xref ref-type="bibr" rid="B42">Pastorino et al., 2018</xref>). Polysaccharides have greater development value and application potential in anti-inflammatory. For example, astragalus polysaccharides reduces gouty arthritis (<xref ref-type="bibr" rid="B43">Ren L. et al., 2022</xref>), lentinan has a good inhibitory effect on neuroinflammation (<xref ref-type="bibr" rid="B64">Zheng et al., 2005</xref>). As one of the main active ingredients of <italic>G. uralensis</italic>, GUP has not only enhanced immune regulation, anti-tumor and antioxidant effects (<xref ref-type="bibr" rid="B6">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B41">Nosalova et al., 2013</xref>; <xref ref-type="bibr" rid="B33">Lian et al., 2018</xref>), but also exhibit anti-inflammatory effects (<xref ref-type="bibr" rid="B21">Huang C. et al., 2022</xref>). Although the anti-inflammatory activity of GUP has been established, the exact mechanism of action and molecular targets remain unclear.</p>
<p>In our research, we aimed to explore the effect of GUP in the treatment of inflammation, particularly in the cGAS-STING pathway-mediated CLP sepsis, and to investigate the underlying mechanisms of its therapeutic role. We found that GUP inhibited the activation of the cGAS-STING pathway by inhibiting the interaction of STING with TBK1 and TBK1 with IRF3, thereby reducing the harm of sepsis.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>2 Methods and materials</title>
<sec id="s2-1">
<title>2.1 Reagents</title>
<p>GUP (WH-0960) was gained from Shanghai Ronghe Medical Technology Development Co., LTD. Its purity was &#x2265;95.0% (purity values are presented by the company) and the original materials of GUP (<italic>G. uralensis</italic>-20210,824-1) was gained from Shanghai Wanshicheng Sinopod Products Co., LTD. Anti-&#x3b1;-tubulin (66031-1-Ig, PTG), anti-Lamin B1 (66095-1-Ig, PTG), anti-IRF3 (11312-1-AP, PTG), anti-HSP90 (13171-1-AP, PTG), anti-hp-IRF3 (ab76493, abcam), anti-STING (19851-1-AP, PTG), anti-mp-IRF3 (GTX86691, GeneTex), anti-HA Tag (66006-2-Ig, PTG), anti-DYKDDDDK tag Polyclonal (20543-1-AP, PTG), HT-DNA (D6898, Sigma), 2&#x2032;3&#x2032;-cGAMP (HY-100564A, MCE), diABZI (HY112921B, MCE), DMXAA (HY-10964, MCE), CCK-8 (KTA1020-1000T), Hoechst (Boston, United States), opti-MEM (2427634, Gibco), Protease inhibitors Cocktail (C0001, TargetMol).</p>
<p>The process of GUP extraction: The <italic>G. uralensis</italic> would be washed, dried, sliced, and then <italic>G. uralensis</italic> with distilled water was put in a vessel, heated, and kept 80&#xb0;C for 2&#xa0;h and stirred regularly. The filtrates were combined and concentrated, extracted three times with ethyl acetate, recovered the aqueous layer and discarded the ethyl acetate. Subsequently, the water layer was placed in AB-8 microporous adsorbent resin, washed with distilled water and recycled water parts. Finally, the recovered water part was dried in a freeze dryer for 48&#xa0;h to access purified GUP (company supplied).</p>
</sec>
<sec id="s2-2">
<title>2.2 Animals</title>
<p>C57BL/6 mice (female, 8 weeks old) were purchased from SPF Biotechnology Co., Ltd. (Beijing, China). Mouse cages were kept pathogen-free (SPF) and provided unrestricted access to food and water. The ambient humidity is 50% &#xb1; 5% and the temperature is 20&#xb0;C&#x2013;22&#xb0;C. We try our best to minimize the number of experimental animals and the least possible suffering of mice during the experiment. The Fifth Medical Center of the Chinese People&#x2019;s Liberation Army General Hospital approved all animal experimental procedures used in this study. These procedures were all carried out in accordance with guidelines for the care and use of laboratory animals (IACUC-2021-0008).</p>
</sec>
<sec id="s2-3">
<title>2.3 The quality control of GUP</title>
<p>We employed Thermo Fisher ICS5000 ion chromatography to analyze the monosaccharide content of GUP. The chromatographic column used is DionexCarbopac<sup>TM</sup>PA20 (3&#x2a;150). The chromatographic mobile phase: solvent A, H<sub>2</sub>O and solvent B, 15&#xa0;mM NaOH and solvent C, 15&#xa0;mM NaOH and 100&#xa0;mM NaOAC. The flow rate was 0.3&#xa0;mL/min, the injection volume was 5&#xa0;&#x3bc;L, and the column temperature was set at 30&#xb0;C. 16 monosaccharide standards including glucose, galactose and glucuronide were dissolved as controls. In the ampoule, the 10&#xa0;mg sample was precisely weighed before 2&#xa0;mL of 3M TFA was inserted and the sample was hydrolyzed at 120&#xb0;C for 3&#xa0;h. The acid hydrolysate was sucked out and blown dry with nitrogen. Add 5&#xa0;mL of water vortexed to mix and draw 50&#xa0;&#xb5;L from it, add 950&#xa0;&#xb5;L of deionized water and centrifuge. Then, it is tested on an ion chromatograph.</p>
</sec>
<sec id="s2-4">
<title>2.4 Cell culture</title>
<p>Mouse bone marrow-derived macrophages (BMDMs) was isolated from bone marrow of 10-week-old female mice and incubated with DMEM medium containing murine macrophage colony-stimulating factor (MCE, Mon-mouth, NJ) with the addition of 1% penicillin/streptomycin (Macgene) and 10% fetal bovine serum (Gibco, Rockford, IL). Human primary monocytes (THP-1) were obtained from ATCC and cultured in RPMI 1640 medium. HEK-293T cells were provided by Tao Li (National Center of Biomedical Analysis) and was cultured in DMEM medium. Healthy volunteers provided the human PBMCs, which were cultivated in RPMI 1640 medium. The cell lines were developed at 37&#xb0;C in an incubator with 5% CO<sub>2</sub> humidity. Human Ethics Number is KY-2023-2-10-1.</p>
</sec>
<sec id="s2-5">
<title>2.5 Cell viability assay</title>
<p>This experiment adopted the Cell Counting Kit 8 (CCK-8) to detect cell viability. The cells were exposed to varying amounts of GUP for a duration of 12&#xa0;h. CCK-8 reagent was co-incubated with the cells in the incubator for a duration of 1&#xa0;h. Finally, optical density values (O.D.) at 450&#xa0;nm were measured. Based on the results of the CCK8 toxicity test for GUP, subsequent experiments were conducted at a non-toxic dose of GUP.</p>
</sec>
<sec id="s2-6">
<title>2.6 Activation of the cGAS-STING pathway</title>
<p>THP-1 cells (with PMA), human PBMCs, BMDMs and were inoculated overnight in well plates respectively at a density of 1.3 &#xd7; 10<sup>6</sup>, 2.5 &#xd7; 10<sup>6</sup> and 1.2 &#xd7; 10<sup>6</sup> cells/mL. Next day, GUP was dissolved in opti-MEM and filtered through a non-pyrogenic filter membrane with a pore size of 0.22&#xa0;&#x3bc;M. The cells were then treated with GUP. After 1&#xa0;h, transfection of HT-DNA (2.5&#xa0;&#x3bc;g/mL) or 2&#x2032;3&#x2032;-cGAMP (2&#xa0;&#x3bc;g/mL), or addition of diABZI (10&#xa0;mmol/mL) or DMXAA (2.5&#xa0;&#x3bc;g/mL) was carried out in the cells. For Western blot analysis, we collected cell lysates after 2&#xa0;h. After 4&#xa0;h, lysates from cells lysed with TRIZOL were collected for qPCR.</p>
</sec>
<sec id="s2-7">
<title>2.7 ELISA</title>
<p>According to the instructions, serum and intraperitoneal lavage liquid of mice were tested by mouse IL-6 (1210602, Dakewe), mouse TNF-&#x3b1; (1217202, Dakewe) and IFN-&#x3b2; (luex-mifnbv2, InvivoGen).</p>
</sec>
<sec id="s2-8">
<title>2.8 Western blotting</title>
<p>The conventional method of protein extraction was used (<xref ref-type="bibr" rid="B53">Wang Z. et al., 2019</xref>). Cell supernatant was collected, and centrifuged for 5 min, and whole cell lysate was prepared using 1&#xd7; RIPA buffer. The supernatant of the centrifuged cell supernatant was then discarded and the fully lysed cell lysate was added. 10% SDS-PAGE was used to separate the protein samples at 100&#xa0;V, and wet transfer was used to transfer the gels onto PVDF membranes. The PVDF membrane was then closed at room temperature in 10% skimmed milk for 1&#xa0;h. We incubated PVDF overnight at 4&#xb0;C with primary antibody, followed by 1&#xa0;h with matched secondary antibody. Washing with TBST was required between each step. Detection of protein bands used enhanced chemiluminescence reagents (Millipore, Massachusetts, United States).</p>
</sec>
<sec id="s2-9">
<title>2.9 Reverse transcriptase quantitative PCR</title>
<p>Total RNA was collected using the TRIZOL reagent (Sigma, 93289) following the guidelines provided by the manufacturer. The RT Master Mix was utilized to transcribe cDNA from RNA in equal quantities (A230, GenStar). The SYBR Green qPCR Master Mix (HY-K0501, MCE) was utilized for conducting real-time PCR. <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="table" rid="T2">Table 2</xref> display the primer sequences.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Mouse primers for quantitative real-time PCR analysis.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Target gene</th>
<th align="left">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse TNF-&#x3b1;-</td>
<td align="left" style="color:#231F20">GGG&#x200b;CAG&#x200b;TTA&#x200b;GGC&#x200b;ATG&#x200b;GGA&#x200b;T</td>
</tr>
<tr>
<td align="left" style="color:#231F20">TGA&#x200b;GCC&#x200b;TTT&#x200b;TAG&#x200b;GCT&#x200b;TCC&#x200b;CAG</td>
</tr>
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse IFN-&#x3b2;</td>
<td align="left" style="color:#231F20">TCC&#x200b;GAG&#x200b;CAG&#x200b;AGA&#x200b;TCT&#x200b;TCA&#x200b;GGA&#x200b;A</td>
</tr>
<tr>
<td align="left" style="color:#231F20">TGCAAC CACCACTCATTCTGAG</td>
</tr>
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse CXCL10</td>
<td align="left" style="color:#231F20">ATCATCCCTG CGAGCCTATCCT</td>
</tr>
<tr>
<td align="left" style="color:#231F20">GAC&#x200b;CTT&#x200b;TTT&#x200b;TGG&#x200b;CTA&#x200b;AAC&#x200b;GCT&#x200b;TTC</td>
</tr>
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse IL-6</td>
<td align="left" style="color:#231F20">CAC&#x200b;TTC&#x200b;ACA&#x200b;AGT&#x200b;CGG&#x200b;AGG&#x200b;CT</td>
</tr>
<tr>
<td align="left" style="color:#231F20">CTG&#x200b;CAA&#x200b;GTG&#x200b;CAT&#x200b;CAT&#x200b;CGT&#x200b;TGT</td>
</tr>
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse GAPDH</td>
<td align="left" style="color:#231F20">CGG&#x200b;AGT&#x200b;CAA&#x200b;CGG&#x200b;ATT&#x200b;TGG&#x200b;TC</td>
</tr>
<tr>
<td align="left" style="color:#231F20">GAC&#x200b;AAG&#x200b;CTT&#x200b;CCC&#x200b;GTT&#x200b;CTC&#x200b;AG</td>
</tr>
<tr>
<td align="left" rowspan="2" style="color:#231F20">Mouse Actin</td>
<td align="left" style="color:#231F20">GGC&#x200b;TGT&#x200b;ATT&#x200b;CCC&#x200b;CTC&#x200b;CAT&#x200b;CG</td>
</tr>
<tr>
<td align="left" style="color:#231F20">CCA&#x200b;GTT&#x200b;GGT&#x200b;AAC&#x200b;AAT&#x200b;GCC&#x200b;ATG&#x200b;T</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Human primers for quantitative real-time PCR analysis.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Target gene</th>
<th align="left">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2">Human TNF-&#x3b1;-</td>
<td align="left">CCT&#x200b;CTC&#x200b;TCT&#x200b;AAT&#x200b;CAG&#x200b;CCC&#x200b;TCT&#x200b;G</td>
</tr>
<tr>
<td align="left">GAG&#x200b;GAC&#x200b;CTG&#x200b;GGA&#x200b;GTA&#x200b;GAT&#x200b;GAG</td>
</tr>
<tr>
<td align="left" rowspan="2">Human IFN-&#x3b2;</td>
<td align="left">TCC&#x200b;AAA&#x200b;TTG&#x200b;CTC&#x200b;TCC&#x200b;TGT&#x200b;TG</td>
</tr>
<tr>
<td align="left">GCA&#x200b;GTA&#x200b;TTC&#x200b;AAG&#x200b;CCT&#x200b;CCC&#x200b;AT</td>
</tr>
<tr>
<td align="left" rowspan="2">Human CXCL10</td>
<td align="left">TGG&#x200b;CAT&#x200b;TCA&#x200b;AGG&#x200b;AGT&#x200b;ACC&#x200b;TC</td>
</tr>
<tr>
<td align="left">TTG&#x200b;TAG&#x200b;CAA&#x200b;TGA&#x200b;TCT&#x200b;CAA&#x200b;CAC&#x200b;G</td>
</tr>
<tr>
<td align="left" rowspan="2">Human IL-6</td>
<td align="left">ACT&#x200b;CAC&#x200b;CTC&#x200b;TTC&#x200b;AGA&#x200b;ACG&#x200b;AAT&#x200b;TG</td>
</tr>
<tr>
<td align="left">CCA&#x200b;TCT&#x200b;TTG&#x200b;GAA&#x200b;GGT&#x200b;TCA&#x200b;GGT&#x200b;TG</td>
</tr>
<tr>
<td align="left" rowspan="2">Human GAPDH</td>
<td align="left">CGG&#x200b;AGT&#x200b;CAA&#x200b;CGG&#x200b;ATT&#x200b;TGG&#x200b;TC</td>
</tr>
<tr>
<td align="left">GAC&#x200b;AAG&#x200b;CTT&#x200b;CCC&#x200b;GTT&#x200b;CTC&#x200b;AG</td>
</tr>
<tr>
<td align="left" rowspan="2">Human Actin</td>
<td align="left">CAT&#x200b;GTA&#x200b;CGT&#x200b;TGC&#x200b;TAT&#x200b;CCA&#x200b;GGC</td>
</tr>
<tr>
<td align="left">CTC&#x200b;CTT&#x200b;AAT&#x200b;GTC&#x200b;ACG&#x200b;CAC&#x200b;GAT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-10">
<title>2.10 Immunoprecipitation assay</title>
<p>For immunoprecipitation assay, HEK-293T cells were inoculated overnight. Cells were transfected with Flag-IRF3 or Flag-TBKI and HA-STING or HA-IRF3 plasmids for 18&#xa0;h. After the treatment with GUP for 4 h, cell pellets were collected and resuspended in lysis buffer (50&#xa0;mM Tris [pH 7.45], 0.5% [v/v] Triton X-100, 150&#xa0;mM NaCl, and 1% [m/v] containing protease inhibitors. In addition, the supernatant was incubated with M2 (A2220, Sigma) beads for 4&#xa0;h at 4&#xb0;C. The samples were washed three times with the lysis buffer, denaturalized by boiling with 1&#xd7;RIPA loading buffer for 15&#xa0;min and analyzed by immunoblotting.</p>
</sec>
<sec id="s2-11">
<title>2.11 STING oligomerization assay</title>
<p>Oligomerization experiments of STING was performed as previously reported (<xref ref-type="bibr" rid="B31">Li S. et al., 2018</xref>). In short, the cell lysates were loaded onto the native-PAGE gel using the native sample buffer, and electrophoresed for 50&#xa0;min at 25&#xa0;mA, and then analyzed by immunoblotting.</p>
</sec>
<sec id="s2-12">
<title>2.12 <italic>In vivo</italic> mice model of STING agonist (DMXAA) and CLP mice model</title>
<p>C57BL/6 wild Eighteen 8-week-old C57 mice were randomized and equally divided into three groups and administered vehicle or GUP (400&#xa0;mg/kg) by gavage for five consecutive days. According to the relevant research reports and the exploration in the early stage of the experiment, we finally determined the dose selection of GUP (400&#xa0;mg/kg) for subsequent animal experiments (<xref ref-type="bibr" rid="B21">Huang C. et al., 2022</xref>; <xref ref-type="bibr" rid="B57">Wu et al., 2022</xref>). On the sixth day, the mice were injected intraperitoneally injection (i.p.) with DMXAA (25&#xa0;mg/mL). DMXAA dose selection as previously described (<xref ref-type="bibr" rid="B26">Khan et al., 2021</xref>). After 4&#xa0;h, the mice were euthanized, intraperitoneal lavage liquid and serum were collected and DMXAA-induced cytokine levels were measured. GUP was dissolved in 0.9% saline and then administered to mice by gavage. DMXAA was dissolved in 1:1 with PEG300: normal saline.</p>
<p>CLP sepsis was induced with C57BL/6 female mice (8&#xa0;weeks old) as mentioned earlier (n &#x003D; 6 mice per group, 18 in total) (<xref ref-type="bibr" rid="B60">Zeng et al., 2017</xref>). In short, the mice were anesthetized and the abdominal surgical area was sterilized. Next, a minor incision was created in the middle of the abdomen, and the cecum was brought outside and secured with silk by tying it. We punctured the ligated portion of the cecum with a 22-gauge needle twice before returning it to the abdominal cavity. Finally, the abdomen was sutured into two layers and mice were immediately injected with saline at 50&#xa0;mg/kg to prevent shock. Sham surgeries involve exteriorizing the cecum and reintroducing it into the abdominal cavity without ligating or puncturing it. Immediately after the operation, Ringer&#x2019;s solution was injected subcutaneously into the mice.</p>
<p>After 72&#xa0;h, the mice were executed through cervical dislocation and lung, heart, liver and kidney tissues were taken. One of the lung tissues was paraffin-embedded, followed by hematoxylin-eosin (H&#x26;E) staining using standard techniques. Heart, liver and kidney tissues were homogenized and then RNA was extracted for qPCR.</p>
</sec>
<sec id="s2-13">
<title>2.13 Statistical analysis</title>
<p>The software GraphPad Prism eight and SPSS statistics 26.0 were utilized for the analysis of all experimental data. The statistical evaluation was conducted by an unpaired Student&#x2019;s t-test between two groups or one-way ANOVA with Dunnett&#x2019;s <italic>post hoc</italic> test was used for multi groups. The results were shown as Mean &#xb1; Standard error of mean (SEM), and <italic>p</italic> values were presented by &#x2a;<italic>p</italic> &#x003c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x003c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x003c; 0.001.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>3 Result</title>
<sec id="s3-1">
<title>3.1 The quality control of GUP and cytotoxic effects of GUP</title>
<p> In order to clarify the evidence for the chemical characterization of GUP, ion chromatography was utilized to determine the monosaccharide composition. The monosaccharide component of GUP was measured by comparison with the reservation time and chromatograph peaks of standard monosaccharides including glucose, galactose and glucuronide acid. Data revealed that the molar ratio of glucose, glucuronide acid and galactose in the GUP sample was 0.902, 0.056, 0.043 respectively (<xref ref-type="sec" rid="s12">Supplementary Figures S1A, B</xref>). The structural features of the GUP were analyzed by FT-IR and the IR spectra were scanned in the range of 4,000-400 cm<sup>-1</sup> and the results are shown in <xref ref-type="sec" rid="s12">Supplementary Figure S1C</xref>. The infrared spectrogram shows the typical characteristics of GUP (<xref ref-type="bibr" rid="B40">Mowat and Agace, 2014</xref>; <xref ref-type="bibr" rid="B41">Nosalova et al., 2013</xref>), from which it can be seen that the broad and strong absorption peak at 3,388.50 cm<sup>-1</sup> is the O-H stretching vibration of the sugar, the smaller absorption peak at 2,929.65 cm<sup>-1</sup> is the stretching vibration of the methyl or methylenecyclohexane C-H, and the peaks between 1,400&#x223c;1,200 cm<sup>-1</sup> are supposed to be the sugar&#x27;s C-H variable angle vibration, from the above it can be determined that GUP is polysaccharide. The peaks at 1,616.80 and 1,416.30 cm<sup>-1</sup> are caused by the asymmetric and symmetric telescopic vibration of C&#x003D;O in saccharide (<xref ref-type="bibr" rid="B42">Pastorino et al., 2018</xref>; <xref ref-type="bibr" rid="B43">Ren et al., 2022a</xref>; <xref ref-type="bibr" rid="B44">Ren et al., 2022b</xref>), which indicates that GUP contains saccharide, and the results of the determination of the composition of monosaccharides containing glucuronide results are consistent with the results. The peaks between 1,200&#x223c;1,000 cm<sup>-1</sup> between 1,200 and 1,000 cm<sup>-1</sup> is the characteristic absorption peak of pyranose (<xref ref-type="bibr" rid="B45">Rizzato et al., 2017</xref>; <xref ref-type="bibr" rid="B46">Schulte et al., 2013</xref>). The above infrared test results indicate that GUP is acidic polysaccharides and contain pyranose rings. Methylation with GC&#x2013;MS is widely used to determine the linkage types and ratios of polysaccharides. The methylated polysaccharide was analyzed by GC&#x2013;MS, and the results were summarized in Table 3, which showed that GUP contained: t-linked Glcp and few t-linked Galp, 1,2-linked Glcp, 1,4-linked Glcp, 1,6- linked Glcp, 1,6-linked Galp. We examined the cytotoxicity of GUP in BMDMs and THP-1 cells to learn more about its impact on cGAS-STING pathway activation. A different concentration of GUP was applied to THP-1 and BMDMs cells for 12 h. As shown (<xref ref-type="sec" rid="s12">Supplementary Figure S2A, B</xref>), GUP had no cytotoxicity at concentrations below 3 mg/mL in both cells. Subsequent experiments were carried out at non-toxic doses.</p>
</sec>
<sec id="s3-2">
<title>3.2 GUP suppresses the activation of HT-DNA-induced cGAS-STING pathway</title>
<p>Researches have shown that HT-DNA enters the cytoplasm through transfection and can be sensed by cGAS and then activate STING (<xref ref-type="bibr" rid="B5">Chanut and Petrilli, 2019</xref>). Monocytes and macrophages, as secretory cells, are essential for the regulation of the immune response and the development of inflammation (<xref ref-type="bibr" rid="B25">Johnston, 1988</xref>). So, we used BMDMs and THP-1 cells to explore whether GUP affected the cGAS-STING pathway. Phosphorylation of IRF3 is a pivotal downstream signaling event in the cGAS-STING pathway. Using immunoblotting analysis to detect related proteins, we found that GUP treatment suppressed the phosphorylation of IRF3 induced by HT-DNA (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>). Meanwhile, we evaluated the effect of GUP on mRNA expression of downstream genes related to this pathway, including IFN-&#x3b2;, IL-6 and TNF-&#x3b1;. Surprisingly, GUP inhibited the mRNA expression of these genes in BMDMs (<xref ref-type="fig" rid="F1">Figures 1C&#x2013;E</xref>) and THP-1 (<xref ref-type="fig" rid="F1">Figures 1F&#x2013;H</xref>) cells. More importantly, GUP also inhibited HT-DNA-induced mRNA expression of IFN-&#x3b2;, IL-6 and TNF-&#x3b1; in human PBMCs (<xref ref-type="fig" rid="F1">Figures 1I&#x2013;K</xref>). In conclusion, these data demonstrate that GUP can suppress the activation of HT-DNA-induced cGAS-STING pathway <italic>in vitro</italic>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>GUP inhibits the activation of HT-DNA-induced cGAS-STING pathway. <bold>(A)</bold> BMDMs and <bold>(B)</bold> THP-1 cells were pretreated with the different concentrations of GUP and then transfected with HT-DNA. Western blotting was conducted to determine phosphorylated p-IRF3, IRF3, p-STING and STING protein levels. Following the steps as above <bold>(A,B)</bold>, HT-DNA was transfected with for 4&#xa0;h. The mRNA expression of IFN-&#x3b2;, TNF-&#x3b1; and IL-6 was measured by quantitative PCR assay in <bold>(C&#x2013;E)</bold> BMDMs cells and <bold>(F&#x2013;H)</bold> THP-1 cells. <bold>(I&#x2013;K)</bold> Human PBMCs. Relative changes were quantified using the &#x394;&#x394;Ct method. The groups were compared using one-way ANOVA statistics. The results were shown as Mean &#xb1; SEM from three biological replicates. &#x2a;&#x2a;<italic>p</italic> &#x003c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x003c; 0.001 vs the stimulated group.</p>
</caption>
<graphic xlink:href="fphar-15-1374179-g001.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 GUP inhibits multiple stimulus-induced activation of the cGAS-STING pathway</title>
<p>We next investigated GUP affects the activation of the cGAS-STING pathway induced by multiple STING agonists. Some natural or enzymatically synthesized STING agonists, such as 2&#x2032;3&#x2032;-cGAMP, diABZI and DMXAA, can also induce the release of type &#x2160; IFNs and other pro-inflammatory factors (<xref ref-type="bibr" rid="B24">Jin et al., 2011</xref>; <xref ref-type="bibr" rid="B39">Messaoud-Nacer et al., 2022</xref>). We further study found that GUP inhibited the phosphorylation of IRF3 induced by various typical STING stimulators (HT-DNA, 2&#x2032;3&#x2032;-cGAMP, diABZI and DMXAA) in BMDMs (<xref ref-type="fig" rid="F2">Figure 2A</xref>) and THP-1 (<xref ref-type="fig" rid="F2">Figure 2F</xref>) cells. In addition, to further validate the above results, we also performed qPCR on its related downstream genes. Interestingly, GUP markedly inhibited the mRNA expression of IFN-&#x3b2;, IL-6, TNF-&#x3b1; and interferon-stimulated genes (CXCL10) activated by multiple STING stimulators in BMDMs (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;E</xref>) and THP-1 (<xref ref-type="fig" rid="F2">Figures 2G&#x2013;J</xref>) cells. All in all, these results strongly demonstrate that GUP has an essential regulatory effect in cGAS-STING pathway activation triggered by multiple stimulus.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>GUP inhibits multiple agonist-induced activation of the cGAS-STING pathway. <bold>(A)</bold> BMDMs and <bold>(F)</bold>THP-1 cells were pretreated with GUP (2&#xa0;mg/mL) and then transfected with 2&#x2032;3&#x2032;-cGAMP and HT-DNA, and addition of diABZI and DMXAA. Phosphorylated expression of p-IRF3, IRF3, p-STING and STING was determined by Western blotting. The mRNA expression of IFN-&#x3b2;, IL-6, TNF-&#x3b1; and CXCL10 was measured by quantitative PCR assay in <bold>(B&#x2013;E)</bold> BMDMs cells and <bold>(G&#x2013;J)</bold> THP-1 cells. Following the steps above <bold>(A,F)</bold>, 2&#x2032;3&#x2032;-cGAMP and HT-DNA was transfected, and diABZI and DMXAA were added for 4&#xa0;h. Statistical comparisons between groups were performed using unpaired two-tailed Student&#x27;s t tests. The results were shown as Mean &#xb1; SEM from three biological replicates, and <italic>p</italic>-value were presented by &#x2a;&#x2a;<italic>p</italic> &#x003c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x003c; 0.001 mock group (no administration) <italic>versus</italic> group (administration).</p>
</caption>
<graphic xlink:href="fphar-15-1374179-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 GUP disrupts nuclear translocation of IRF3</title>
<p>Nuclear translocation is an important function in transcription. IRF3 is phosphorylated to form a dimer that translocate to the nucleus and thereby regulates the expression of type I IFNs (<xref ref-type="bibr" rid="B61">Zhang et al., 2019</xref>). Here, we explored whether GUP could inhibit the nuclear translocation of IRF3, thereby suppressing transcriptional activity. As shown in the picture (<xref ref-type="fig" rid="F3">Figure 3B</xref>), GUP inhibited the nuclear accumulation of IRF3. To verify these results, we performed an immunofluorescence assay. Our results showed (<xref ref-type="fig" rid="F3">Figure 3A</xref>), GUP significantly reduces diABZI induced nuclear aggregation of IRF3. The present study demonstrated that GUP blocked IRF3 transcriptional activity and thereby suppressed the expression of type I IFNs.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>GUP disrupts nuclear translocation of IRF3 and inhibits STING-TBK1 and TBK1-IRF3 interactions. <bold>(A)</bold> THP-1cells were treated with GUP for 1&#xa0;h, followed by stimulation with diABZI for 2&#xa0;h and stained for IRF3. The blue Hoechst (nucleus) image is superimposed on the green IRF3 image. At 20 original magnification, pictures were shot for each circumstance. Scale bars represent 10&#xa0;&#x3bc;m. <bold>(B)</bold> 2&#x2032;3&#x2032;-cGAMP was transfected into THP-1 cells for 2&#xa0;h after GUP treatment for 1&#xa0;h. Protein expression in cytosolic and nuclear lysate of THP-1 cells treated with GUP were analyzed by Western blot to determine the cellular distribution of IRF3. <bold>(C)</bold> GUP was pretreated for 1&#xa0;h in BMDMs, and then 2&#x2032;3&#x2032;-cGAMP was transfected for 1&#xa0;h in the cells. Collection of lysates for immunoblotting to detect phosphorylation and oligomerization of STING. <bold>(D)</bold> Flag-TBK1 or <bold>(E)</bold> Flag-IRF3 plasmids was co-transfected with HA-STING plasmids. <bold>(F)</bold> Flag-TBK1 plasmids was co-transfected with HA-IRF3 plasmids. HEK-293T cells were treated with GUP for 4&#xa0;h after 18&#xa0;h of transfection. The anti-DYKDDDDK (Flag) affinity gel agarose beads were used for immunoprecipitation. Finally, we performed immunoblot analysis.</p>
</caption>
<graphic xlink:href="fphar-15-1374179-g003.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 GUP suppresses the activation of cGAS-STING pathway by inhibiting STING-TBK1 and TBK1-IRF3 interactions</title>
<p>Next, we aim to explore the mechanisms by which GUP influences cGAS-STING pathway activation. Our previous research demonstrated that GUP could suppress the phosphorylation and nuclear translocation of IRF3, a key downstream signaling event in this signaling pathway. Therefore, we will further explore the role of GUP on the upstream of this pathway. Studies have shown that cGAMP causes a conformational change in STING, resulting in oligomerization of STING and subsequently recruits TBK1 to activate downstream pathways. However, our results indicated that GUP did not inhibit 2&#x2032;3&#x2032;-cGAMP-induced STING oligomerization (<xref ref-type="fig" rid="F3">Figure 3C</xref>). STING is a scaffold protein that, upon binding to CDNs, recruits downstream signaling proteins (<xref ref-type="bibr" rid="B31">Li S. et al., 2018</xref>). After STING recruits TBK1, IRF-3 transcription factors are subsequently recruited to the signaling complex and phosphorylated by TBK1, which then regulates downstream pathways (<xref ref-type="bibr" rid="B62">Zhao et al., 2019</xref>; <xref ref-type="bibr" rid="B44">Ren Y. et al., 2022</xref>). Thus, binding between STING, TBK1 and IRF3 is necessary for activating cGAS-STING pathway. To this end, we examined whether GUP inhibited the interaction between three key proteins in this pathway, STING, TBK1 and IRF3. Notably, our results showed that in exogenous scenarios, GUP inhibited STING interactions with TBK1 (<xref ref-type="fig" rid="F3">Figure 3D</xref>) and TBK1 interactions with IRF3 (<xref ref-type="fig" rid="F3">Figure 3E</xref>), but not STING-IRF3 interactions (<xref ref-type="fig" rid="F3">Figure 3F</xref>). In conclusion, these results suggest that GUP inhibits the activation of the cGAS-STING pathway by inhibiting the interaction of STING with TBK1 and TBK1 with IRF3.</p>
</sec>
<sec id="s3-6">
<title>3.6 GUP inhibits the activation of cGAS-STING <italic>in vivo</italic>
</title>
<p>Our next step was to investigate how GUP affects the activation of the cGAS-STING pathway <italic>in vivo</italic>. DMXAA, a mouse interferon gene (STING) stimulator (<xref ref-type="bibr" rid="B58">Xu et al., 2021</xref>), was also a potent inducer of type I IFNs and inflammatory cytokines, so we chose DMXAA for our <italic>in vivo</italic> study. Mouse were given GUP (400&#xa0;mg/kg/day) for 5&#xa0;days and DMXAA was injected intraperitoneally on the sixth day. After 4&#xa0;h, serum and intraperitoneal lavage liquid were gathered from the mouse and the expression of IFN-&#x3b2;, IL-6 and TNF-&#x3b1; in the serum and intraperitoneal lavage fluid were measured by Elisa kits. Our results showed that DMXAA stimulation raised the expression of IFN-&#x3b2;, IL-6 and TNF-&#x3b1; in the intraperitoneal lavage liquid (<xref ref-type="fig" rid="F4">Figures 4B&#x2013;D</xref>) and serum (<xref ref-type="fig" rid="F4">Figures 4E&#x2013;G</xref>) of mouse. Notably, GUP markedly decreased DMXAA-mediated expression of IFN-&#x3b2;, IL-6 and TNF-&#x3b1;. Thus, GUP can inhibit the activation of the cGAS-STING pathway <italic>in vivo</italic>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>GUP suppresses the activation of cGAS-STING <italic>in vivo</italic>. <italic>In vivo</italic> experiments of DMXAA-induced activation of STING and its downstream signaling pathways <italic>in vivo</italic> <bold>(A)</bold>, the levels of IFN-&#x3b2;, IL-6 and TNF-&#x3b1; respectively in the <bold>(B&#x2013;D)</bold> intraperitoneal lavage and <bold>(E&#x2013;G)</bold> serum of mice after 4&#xa0;h of DMXAA induction were determined by ELISA. Data were displayed by Mean &#xb1; SEM (n &#x003D; 6 mice per group). The groups were compared using one-way ANOVA statistics. <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x003c; 0.001, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x003c; 0.001 <italic>versus</italic> the DMXAA group. (n &#x003D; 6 mice per group).</p>
</caption>
<graphic xlink:href="fphar-15-1374179-g004.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 GUP alleviates CLP through regulating cGAS-STING pathway</title>
<p>Study showed significant activation of cGAS-STING pathway in Cecal Ligation and Puncture (CLP)-induced sepsis (<xref ref-type="bibr" rid="B29">Li J. et al., 2022</xref>). In recent years, various models of sepsis have been studied, and CLP model is the most associated animal model for clinical sepsis (<xref ref-type="bibr" rid="B4">Buras et al., 2005</xref>; <xref ref-type="bibr" rid="B11">Dejager et al., 2011</xref>). To determine the effect of GUP on sepsis, CLP was conducted following the previous description (<xref ref-type="bibr" rid="B60">Zeng et al., 2017</xref>). GUP (400&#xa0;mg/kg/day) was treated to mouse for 5&#xa0;days before CLP and repeated oral administration to mouse at 12, 24, 48 and 72&#xa0;h after CLP. Through the analysis of H&#x26;E staining of lung and intestinal tissues of mouse, we found that CLP-induced lung and intestine increased leukocyte infiltration and significant accumulation of inflammatory cells in the alveolar space, in accordance with previous researches (<xref ref-type="bibr" rid="B60">Zeng et al., 2017</xref>). Our results showed that GUP reduces damage to lung and intestinal tissues (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Furthermore, in CLP-induced heart, liver and kidney tissues, the mRNA expression of IFN-&#x3b2; and TNF-&#x3b1; was increased at 72&#xa0;h, whereas GUP decreased the mRNA expression of IFN-&#x3b2; (<xref ref-type="fig" rid="F5">Figures 5B&#x2013;D</xref>) and TNF-&#x3b1; (<xref ref-type="fig" rid="F5">Figures 5E&#x2013;G</xref>). In general, these data suggest a protective effect of GUP against CLP sepsis. Combining the results of previous experiments and the action of the cGAS-STING pathway in the inflammatory response (<xref ref-type="bibr" rid="B10">Decout et al., 2021</xref>), we speculate that GUP may exert its anti-inflammatory effects by down-regulating the cGAS-STING pathway.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>GUP alleviated CLP through regulating cGAS-STING signaling pathway. <bold>(A)</bold> H&#x26;E staining of lung and intestine tissues. Scale bar: 100&#xa0;&#x3bc;m. (<italic>n</italic> &#x003D; 6 mice per group). <bold>(B&#x2013;D)</bold> IFN-&#x3b2; and <bold>(E&#x2013;G)</bold> TNF-&#x3b1; cytokine mRNA in Kidney, Heart and Liver. One-way ANOVA statistics were used to compare the groups. The results were shown as Mean &#xb1; SEM. <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x003c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x003c; 0.001 means compared to the control group; &#x2a;&#x2a;<italic>p</italic> &#x003c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x003c; 0.001 <italic>versus</italic> the CLP group (n &#x003D; 6 mice per group).</p>
</caption>
<graphic xlink:href="fphar-15-1374179-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>4 Discussion</title>
<p>Studies have indicated that the cGAS-STING pathway is significantly expressed in a variety of inflammatory diseases, such as sepsis (<xref ref-type="bibr" rid="B29">Li J. et al., 2022</xref>), kidney injury (<xref ref-type="bibr" rid="B38">Maekawa et al., 2019</xref>) and lung injury (<xref ref-type="bibr" rid="B22">Huang R. et al., 2022</xref>). Sepsis is an acute disease caused by an infection or trauma resulting in a systemic inflammatory response caused by microbial invasion, resulting in a dysregulated host response leading to organ dysfunction (<xref ref-type="bibr" rid="B13">Evans, 2018</xref>). The search for an inhibitor targeting the regulation of the cGAS-STING pathway is a promising line of research for the treatment of sepsis. <italic>Glycyrrhiza uralensis</italic> is a traditional medicinal plant that has demonstrated antiviral and anti-inflammatory activity (<xref ref-type="bibr" rid="B51">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="B59">Yang et al., 2017</xref>; <xref ref-type="bibr" rid="B1">Babu et al., 2023</xref>). This article reports that GUP, the main active constituent of <italic>G. uralensis</italic>, suppressed the activation of cGAS-STING both <italic>in vitro</italic> and <italic>in vivo</italic>, revealing the effect of GUP in regulating cGAS-STING-mediated sepsis.</p>
<p>It has been previously reported that GUP have antioxidation, antibacterial and anti-tumor activities, but little research has been done on anti-inflammatory activities (<xref ref-type="bibr" rid="B33">Lian et al., 2018</xref>; <xref ref-type="bibr" rid="B19">Hao et al., 2020</xref>). Zhao et al. found that GUP alleviated the symptoms of DSS-induced UC mice by suppressing the expression of IL-1, IL-6 and TNF-&#x3b1; in serum (<xref ref-type="bibr" rid="B21">Huang C. et al., 2022</xref>). Although its anti-inflammatory effects have been studied to some extent, its exact mechanism of action and targets are not yet clear. Our research showed that GUP inhibited the phosphorylation of IRF3 and the expression of mRNA of related downstream gene to the cGAS-STING signaling pathway, such as IFN-&#x3b2;, IL-6, TNF-&#x3b1; and CXCL10 induced by various canonical cGAS- STING agonists (HT-DNA, 2&#x2032;3&#x2032;- cGAMP, diABZI and DMXAA). This indicates that GUP can influence the aberrant activation of the cGAS-STING pathway and is a broad-spectrum inhibitor of the cGAS-STING pathway with inhibition of the pathway <italic>in vitro</italic>. Previous research has revealed that the STING agonist DMXAA causes systemic inflammatory responses and shock-like symptoms in mice (<xref ref-type="bibr" rid="B2">Brault et al., 2018</xref>). It is noteworthy that GUP markedly suppressed the release of systemic cytokine in DMXAA-induced mice. This results showed that GUP can suppress the activation of the cGAS-STING pathway <italic>in vivo</italic>. However, DMXA has not been shown to be an agonist for human STING, so it remains to be investigated whether GUP can effectively inhibit the activation of the cGAS-STING pathway in humans.</p>
<p>STING is activated by cGAMP and recruits TBK1 and IRF3. IRF3 forms a complex with STING and TBK1 and is phosphorylated by TBK1, thereby regulating downstream gene expression (<xref ref-type="bibr" rid="B16">Ghosh et al., 2021</xref>). Studies demonstrate that the interaction between three proteins, STING, TBK1 and IRF3 are important for the activation of the cGAS-STING pathway (<xref ref-type="bibr" rid="B31">Li S. et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Ghosh et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Ren Y. et al., 2022</xref>). In previous study, Licorice flavonoids were indicated to have a good therapeutic effect on acute lung injury induced by LPS, which may act by acting upstream of the cGAS-STING pathway and reducing the synthesis of cGAMP. Licorice extract, on the other hand, can treat MCD-induced NASH mice, and its mechanism of action is to affect the oligomerization of STING. Glabridin and Licochalcone B, as the main active ingredients in licorice, showed promising ameliorative effects on autoimmune diseases contributed to <italic>Trex1</italic> knockout, and their mechanism of action may be related to affecting the binding of IRF3 with STING. Our results indicate that GUP inhibits the cGAS-STING pathway by affecting STING-TBK1 and TBK1-IRF3 interactions. This indicates that although different components of <italic>Glycyrrhiza glabra</italic> have inhibitory effects on the cGAS-STING pathway, the exact mechanism of action is not the same, which also well explains the &#x201c;multi-component, multi-pathway, multi-target&#x201d; action characteristics of traditional Chinese medicine. Our study also undoubtedly further enriches the scientific connotation of licorice in &#x201c;clearing heat and removing toxins&#x201d;. However, it is precisely because gup contains various monomeric components that its direct action and targeting of proteins need to be further investigated.</p>
<p>Sepsis is a systemic infectious disease caused by toxins from bacteria, fungi or other microorganisms. Research indicates that there is a strong correlation between Intestinal bacteria and sepsis (<xref ref-type="bibr" rid="B3">Buffie and Pamer, 2013</xref>). Intestinal bacteria, which are the basis of intestinal metabolites, can reduce the risk of sepsis by regulating beneficial bacteria in the gut such as Bifidobacteria and Lactobacilli to promote the integrity of the intestinal mucosal barrier and reduce the number of harmful bacteria (<xref ref-type="bibr" rid="B40">Mowat and Agace, 2014</xref>; <xref ref-type="bibr" rid="B8">Chen Y. et al., 2021</xref>). At the same time, changes in intestinal bacteria may also contribute to abnormal activation of the immune system, leading to an excessive inflammatory response, which in turn exacerbates sepsis (<xref ref-type="bibr" rid="B52">Wang et al., 2022</xref>). Improving intestinal flora is an effective treatment for sepsis, but finding a precursor compound that is effective in treating sepsis is more responsive to clinical needs. Our ultimate aim is to assess the therapeutic potential of GUP for CLP sepsis.</p>
<p>Walker&#x2019;s group demonstrated for the first time that <italic>STING</italic> knockout mice were protected from CLP induced sepsis (<xref ref-type="bibr" rid="B20">Heipertz et al., 2017</xref>). Li&#x2019;s laboratory further demonstrated increased cGAS-STING pathway in human sepsis and discovered that blocking cGAS-STING pathway prevented sepsis-associated acute liver injury (<xref ref-type="bibr" rid="B29">Li J. et al., 2022</xref>). These data confirm the importance of the cGAS-STING pathway in the development of sepsis. The release of inflammatory cytokines often leads to sepsis and suppression of inflammation is a strategy for treating sepsis (<xref ref-type="bibr" rid="B46">Schulte et al., 2013</xref>). In previous studies, type I IFNs is an essential cytokine that promotes and regulates immune and inflammatory responses, and its inappropriate expression leads to the death of various cells, which is essential for the septicemic response (<xref ref-type="bibr" rid="B17">Gonz&#xe1;lez-Navajas et al., 2012</xref>; <xref ref-type="bibr" rid="B32">Li Y. et al., 2018</xref>). TNF-&#x3b1; is a key immune system regulator whose overexpression may contribute to the development of inflammatory disorders (<xref ref-type="bibr" rid="B12">Dinarello, 2000</xref>). Our results showed that CLP mice showed dysfunction of the heart, liver and kidney, such as increased release of IFN-&#x3b2; and TNF-&#x3b1;, which was in accordance with previous findings (<xref ref-type="bibr" rid="B60">Zeng et al., 2017</xref>). H&#x26;E staining of the lung and intestine tissues also showed some degree of damage to the lung tissue. Surprisingly, the GUP treatment improved these symptoms. In view of the above results, we hypothesize that the ameliorative effect of GUP on CLP sepsis may act by mediating immune-related pathways, especially the cGAS-STING pathway. However, whether GUP has a protective effect against other cGAS-STING-mediated inflammatory diseases needs to be further explored.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<title>5 Conclusion</title>
<p>Our study identifies a potent inhibitor of the cGAS-STING pathway. GUP inhibited the activation of the cGAS-STING pathway <italic>in vitro</italic> and <italic>in vivo</italic>, reducing the expression of related downstream gene. Mechanistically, GUP inhibited the cGAS-STING pathway by inhibiting the interaction of STING with TBK1 and TBK1 with IRF3. At the same time, it also provides a potential therapeutic agent for cGAS-STING pathway-induced related inflammatory diseases, particularly sepsis.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p> All of our experimental protocols have been approved by the Animal Ethics Committee of the Fifth Medical Center, Chinese People&#x27;s Liberation Army (PLA) General Hospital (Beijing, China).</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>SH: Conceptualization, Investigation, Writing&#x2013;review and editing. WK: Writing&#x2013;review and editing. SQ: Conceptualization, Writing&#x2013;review and editing. Ping He: Investigation, Writing&#x2013;review and editing. JZ: Writing&#x2013;review and editing. HL: Methodology, Writing&#x2013;review and editing. JB: Project administration, Writing&#x2013;review and editing. JW: Conceptualization, Writing&#x2013;review and editing. WM: Supervision, Writing&#x2013;review and editing. MH: Validation, Writing&#x2013;review and editing. ZW: Funding acquisition, Writing&#x2013;review and editing. LL: Project administration, Writing&#x2013;review and editing. XX: Resources, Visualization, Writing&#x2013;review and editing. GX: Data curation, Methodology, Writing&#x2013;review and editing. ZB: Data curation, Methodology, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was granted by Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202005), Capital&#x2019;s Funds for Health Improvement and Research (CFH 2022-4-5062), the State Key Program of National Natural Science of China (Grant No. 81930110, No.82230118) China Postdoctoral Science Foundation (2021M693961) and supported by Beijing Natural Science Foundation (7232321).</p>
</sec>
<ack>
<p>We are grateful to all the researchers who participated in this study.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2024.1374179/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2024.1374179/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.zip" id="SM1" mimetype="application/zip" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kapkoti</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Binwal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhakuni</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Shanker</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Liquiritigenin, isoliquiritigenin rich extract of glycyrrhiza glabra roots attenuates inflammation in macrophages and collagen-induced arthritis in rats</article-title>. <source>Inflammopharmacology</source> <volume>31</volume> (<issue>2</issue>), <fpage>983</fpage>&#x2013;<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1007/s10787-023-01152-w</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brault</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stetson</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Oberst</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Intracellular nucleic acid sensing triggers necroptosis through synergistic type I IFN and TNF signaling</article-title>. <source>J. Immunol.</source> <volume>200</volume> (<issue>8</issue>), <fpage>2748</fpage>&#x2013;<lpage>2756</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1701492</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buffie</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Pamer</surname>
<given-names>E. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Microbiota-mediated colonization resistance against intestinal pathogens</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume> (<issue>11</issue>), <fpage>790</fpage>&#x2013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1038/nri3535</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buras</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Holzmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sitkovsky</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Animal models of sepsis: setting the stage</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>4</volume> (<issue>10</issue>), <fpage>854</fpage>&#x2013;<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1038/nrd1854</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanut</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Petrilli</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cytosolic DNA sensing by the cGAS-STING pathway in cancer</article-title>. <source>Med. Sci. Paris.</source> <volume>35</volume> (<issue>6-7</issue>), <fpage>527</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1051/medsci/2019095</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway</article-title>. <source>Tumour Biol.</source> <volume>34</volume> (<issue>3</issue>), <fpage>1381</fpage>&#x2013;<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-013-0746-7</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>The role of cGAS-STING signalling in liver diseases</article-title>. <source>JHEP Rep.</source> <volume>3</volume> (<issue>5</issue>), <fpage>100324</fpage>. <pub-id pub-id-type="doi">10.1016/j.jhepr.2021.100324</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>761981</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.761981</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hoeft</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Book</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Pastores</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Sepsis: pathogenesis, biomarkers, and treatment</article-title>. <source>Biomed. Res. Int.</source> <volume>2015</volume>, <fpage>846935</fpage>. <pub-id pub-id-type="doi">10.1155/2015/846935</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decout</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Venkatraman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ablasser</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The cGAS-STING pathway as a therapeutic target in inflammatory diseases</article-title>. <source>Nat. Rev. Immunol.</source> <volume>21</volume> (<issue>9</issue>), <fpage>548</fpage>&#x2013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-021-00524-z</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dejager</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dejonckheere</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Libert</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?</article-title> <source>Trends Microbiol.</source> <volume>19</volume> (<issue>4</issue>), <fpage>198</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2011.01.001</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinarello</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Proinflammatory cytokines</article-title>. <source>Chest</source> <volume>118</volume> (<issue>2</issue>), <fpage>503</fpage>&#x2013;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1378/chest.118.2.503</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Diagnosis and management of sepsis</article-title>. <source>Clin. Med. (Lond)</source> <volume>18</volume> (<issue>2</issue>), <fpage>146</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.7861/clinmedicine.18-2-146</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleischmann-Struzek</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mellhammar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cassini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rudd</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Schlattmann</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis</article-title>. <source>Intensive Care Med.</source> <volume>46</volume> (<issue>8</issue>), <fpage>1552</fpage>&#x2013;<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-020-06151-x</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fr&#xe9;mond</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>STING-mediated lung inflammation and beyond</article-title>. <source>J. Clin. Immunol.</source> <volume>41</volume> (<issue>3</issue>), <fpage>501</fpage>&#x2013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-021-00974-z</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bettke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nagar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parrales</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iwakuma</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mutant p53 suppresses innate immune signaling to promote tumorigenesis</article-title>. <source>Cancer Cell</source> <volume>39</volume> (<issue>4</issue>), <fpage>494</fpage>&#x2013;<lpage>508.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2021.01.003</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Navajas</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Raz</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Immunomodulatory functions of type I interferons</article-title>. <source>Nat. Rev. Immunol.</source> <volume>12</volume> (<issue>2</issue>), <fpage>125</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1038/nri3133</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation</article-title>. <source>Int. Immunopharmacol.</source> <volume>108</volume>, <fpage>108730</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2022.108730</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Laba</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Preparation of complex microcapsules of soluble polysaccharide from Glycyrrhiza uralensis and its application in wound repair and scar inhibition</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>156</volume>, <fpage>906</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.03.121</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heipertz</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>W. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>STING and TRIF contribute to mouse sepsis, depending on severity of the disease model</article-title>. <source>Shock</source> <volume>47</volume> (<issue>5</issue>), <fpage>621</fpage>&#x2013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1097/SHK.0000000000000771</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Glycyrrhiza polysaccharide alleviates dextran sulfate sodium-induced ulcerative colitis in mice</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2022</volume>, <fpage>1345852</fpage>. <pub-id pub-id-type="doi">10.1155/2022/1345852</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Inhibition of the cGAS-STING pathway attenuates lung ischemia/reperfusion injury via regulating endoplasmic reticulum stress in alveolar epithelial type II cells of rats</article-title>. <source>J. Inflamm. Res.</source> <volume>15</volume>, <fpage>5103</fpage>&#x2013;<lpage>5119</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S365970</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Corrigendum to "An "essential herbal medicine"-licorice: a review of phytochemicals and its effects in combination preparations" [J. Ethnopharmacol. 249 (2020) 112439]</article-title>. <source>J. Ethnopharmacol.</source> <volume>299</volume>, <fpage>115706</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2022.115706</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Filak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mogan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP</article-title>. <source>J. Immunol.</source> <volume>187</volume> (<issue>5</issue>), <fpage>2595</fpage>&#x2013;<lpage>2601</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1100088</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>R. B.</given-names>
<suffix>Jr</suffix>
</name>
</person-group> (<year>1988</year>). <article-title>Current concepts: immunology. Monocytes and macrophages</article-title>. <source>N. Engl. J. Med.</source> <volume>318</volume> (<issue>12</issue>), <fpage>747</fpage>&#x2013;<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198803243181205</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>I. U.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Fever-range hyperthermia promotes cGAS-STING pathway and synergizes DMXAA-induced antiviral immunity</article-title>. <source>Int. J. Hyperth.</source> <volume>38</volume> (<issue>1</issue>), <fpage>30</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1080/02656736.2020.1868582</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bakhoum</surname>
<given-names>S. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The cytosolic DNA-sensing cGAS-STING pathway in cancer</article-title>. <source>Cancer Discov.</source> <volume>10</volume> (<issue>1</issue>), <fpage>26</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-0761</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>cGAS-STING pathway aggravates early cerebral ischemia-reperfusion injury in mice by activating NCOA4-mediated ferritinophagy</article-title>. <source>Exp. Neurol.</source> <volume>359</volume>, <fpage>114269</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2022.114269</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Blocking cGAS/STING signaling protects against sepsis-associated acute liver injury</article-title>. <source>Int. Immunopharmacol.</source> <volume>113</volume> (<issue>Pt A</issue>), <fpage>109276</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2022.109276</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction</article-title>. <source>EMBO Rep.</source> <volume>23</volume> (<issue>2</issue>), <fpage>e53499</fpage>. <pub-id pub-id-type="doi">10.15252/embr.202153499</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018a</year>). <article-title>The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING</article-title>. <source>Cell Rep.</source> <volume>25</volume> (<issue>12</issue>), <fpage>3405</fpage>&#x2013;<lpage>3421</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.097</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2018b</year>). <article-title>Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection</article-title>. <source>Cell Death Differ.</source> <volume>25</volume> (<issue>7</issue>), <fpage>1304</fpage>&#x2013;<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-017-0041-z</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lian</surname>
<given-names>K. X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X. L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Selenylation modification: enhancement of the antioxidant activity of a Glycyrrhiza uralensis polysaccharide</article-title>. <source>Glycoconj J.</source> <volume>35</volume> (<issue>2</issue>), <fpage>243</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1007/s10719-018-9817-8</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Research progress on structural modification of effective antitumor active ingredients in licorice</article-title>. <source>Molecules</source> <volume>28</volume> (<issue>15</issue>), <fpage>5855</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28155855</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>LicochalconeB inhibits cGAS-STING signaling pathway and prevents autoimmunity diseases</article-title>. <source>Int. Immunopharmacol.</source> <volume>128</volume>, <fpage>111550</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2024.111550</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis</article-title>. <source>Front. Pharmacol.</source> <volume>14</volume>, <fpage>1160445</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2023.1160445</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>18&#x3b2;-Glycyrrhetinic acid has anti-cancer effects via inducing apoptosis and G2/M cell cycle arrest, and inhibiting migration of A549 lung cancer cells</article-title>. <source>Onco Targets Ther.</source> <volume>14</volume>, <fpage>5131</fpage>&#x2013;<lpage>5144</lpage>. <pub-id pub-id-type="doi">10.2147/OTT.S322852</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maekawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ouchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jao</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nishi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury</article-title>. <source>Cell Rep.</source> <volume>29</volume> (<issue>5</issue>), <fpage>1261</fpage>&#x2013;<lpage>1273</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.050</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messaoud-Nacer</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Culerier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maillet</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rouxel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Briault</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)</article-title>. <source>Cell Death Dis.</source> <volume>13</volume> (<issue>3</issue>), <fpage>269</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-022-04664-5</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mowat</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Agace</surname>
<given-names>W. W.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Regional specialization within the intestinal immune system</article-title>. <source>Nat. Rev. Immunol.</source> <volume>14</volume> (<issue>10</issue>), <fpage>667</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1038/nri3738</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nosalova</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fleskova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jurecek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sadlonova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Herbal polysaccharides and cough reflex</article-title>. <source>Respir. Physiol. Neurobiol.</source> <volume>187</volume> (<issue>1</issue>), <fpage>47</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2013.03.015</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pastorino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cornara</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review</article-title>. <source>Phytother. Res.</source> <volume>32</volume> (<issue>12</issue>), <fpage>2323</fpage>&#x2013;<lpage>2339</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.6178</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Polysaccharide extract from Isatidis Radix inhibits multiple inflammasomes activation and alleviate gouty arthritis</article-title>. <source>Phytother. Res.</source> <volume>36</volume> (<issue>8</issue>), <fpage>3295</fpage>&#x2013;<lpage>3312</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.7514</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Dual inhibition of innate immunity and apoptosis by human cytomegalovirus protein UL37x1 enables efficient virus replication</article-title>. <source>Nat. Microbiol.</source> <volume>7</volume> (<issue>7</issue>), <fpage>1041</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-022-01136-6</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzato</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Scalabrin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Radaelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Capodaglio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A new exploration of licorice metabolome</article-title>. <source>Food Chem.</source> <volume>221</volume>, <fpage>959</fpage>&#x2013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2016.11.068</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulte</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bucala</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view</article-title>. <source>Mediat. Inflamm.</source> <volume>2013</volume>, <fpage>165974</fpage>. <pub-id pub-id-type="doi">10.1155/2013/165974</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deutschman</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Seymour</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Shankar-Hari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Annane</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source>Jama</source> <volume>315</volume> (<issue>8</issue>), <fpage>801</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The licorice flavonoid isoliquiritigenin attenuates Mycobacterium tuberculosis-induced inflammation through Notch1/NF-&#x3ba;B and MAPK signaling pathways</article-title>. <source>J. Ethnopharmacol.</source> <volume>294</volume>, <fpage>115368</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2022.115368</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahab</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Annadurai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abullais</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology</article-title>. <source>Plants (Basel)</source> <volume>10</volume> (<issue>12</issue>), <fpage>2751</fpage>. <pub-id pub-id-type="doi">10.3390/plants10122751</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019a</year>). <article-title>Accumulation of cytosolic dsDNA contributes to fibroblast-like synoviocytes-mediated rheumatoid arthritis synovial inflammation</article-title>. <source>Int. Immunopharmacol.</source> <volume>76</volume>, <fpage>105791</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2019.105791</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb</article-title>. <source>Acta Pharm. Sin. B</source> <volume>5</volume> (<issue>4</issue>), <fpage>310</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2015.05.005</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H. Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Anti-hyperglycemic agents in the adjuvant treatment of sepsis: improving intestinal barrier function</article-title>. <source>Drug Des. Devel Ther.</source> <volume>16</volume>, <fpage>1697</fpage>&#x2013;<lpage>1711</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S360348</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019b</year>). <article-title>Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome</article-title>. <source>Acta Pharm. Sin. B</source> <volume>9</volume> (<issue>4</issue>), <fpage>734</fpage>&#x2013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2019.02.003</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2023a</year>). <article-title>Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production</article-title>. <source>Mol. Med.</source> <volume>29</volume> (<issue>1</issue>), <fpage>167</fpage>. <pub-id pub-id-type="doi">10.1186/s10020-023-00754-y</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>Flavonoids derived from licorice suppress LPS-induced acute lung injury in mice by inhibiting the cGAS-STING signaling pathway</article-title>. <source>Food Chem. Toxicol.</source> <volume>175</volume>, <fpage>113732</fpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2023.113732</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA</article-title>. <source>Science</source> <volume>339</volume> (<issue>6121</issue>), <fpage>826</fpage>&#x2013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1126/science.1229963</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Glycyrrhiza polysaccharides can improve and prolong the response of chickens to the Newcastle disease vaccine</article-title>. <source>Poult. Sci.</source> <volume>101</volume> (<issue>1</issue>), <fpage>101549</fpage>. <pub-id pub-id-type="doi">10.1016/j.psj.2021.101549</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Robeson</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Shou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bommiasamy</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Laurie</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>STING agonist promotes CAR T cell trafficking and persistence in breast cancer</article-title>. <source>J. Exp. Med.</source> <volume>218</volume> (<issue>2</issue>), <fpage>e20200844</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20200844</pub-id>
</citation>
</ref>
<ref id="bib66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>9900</year>). <article-title>
<italic>Crocus sativus</italic> <italic>L.</italic> produces anti-inflammatory effects and regulates NLRP3&#x2013;NF-&#x3ba;B pathway</article-title>. <source>Acupun. and Herbal Medi.</source> <pub-id pub-id-type="doi">10.1097/HM1099.0000000000000088</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The anti-inflammatory activity of licorice, a widely used Chinese herb</article-title>. <source>Pharm. Biol.</source> <volume>55</volume> (<issue>1</issue>), <fpage>5</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2016.1225775</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>ALK is a therapeutic target for lethal sepsis</article-title>. <source>Sci. Transl. Med.</source> <volume>9</volume> (<issue>412</issue>), <fpage>eaan5689</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aan5689</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>X. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Structural basis of STING binding with and phosphorylation by TBK1</article-title>. <source>Nature</source> <volume>567</volume> (<issue>7748</issue>), <fpage>394</fpage>&#x2013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1000-2</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sankaran</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>S. L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1</article-title>. <source>Nature</source> <volume>569</volume> (<issue>7758</issue>), <fpage>718</fpage>&#x2013;<lpage>722</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1228-x</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Glycyrrhizic acid prevents sepsis-induced acute lung injury and mortality in rats</article-title>. <source>J. Histochem Cytochem</source> <volume>64</volume> (<issue>2</issue>), <fpage>125</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1369/0022155415610168</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hanchuan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moucheng</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Characterization and immunomodulating activities of polysaccharide from Lentinus edodes</article-title>. <source>Int. Immunopharmacol.</source> <volume>5</volume> (<issue>5</issue>), <fpage>811</fpage>&#x2013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2004.11.011</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoulikha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Boafo</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Sallam</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome</article-title>. <source>Acta Pharm. Sin. B</source> <volume>12</volume> (<issue>2</issue>), <fpage>600</fpage>&#x2013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2021.08.009</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>